Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroblastoma × Immunoglobulin G × CNS × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 10 Brain Neoplasms 6 Gliosarcoma 4 Oligodendroglioma 3 Glioma 3 Astrocytoma 3 Spinal Cord Neoplasms 2 Medulloblastoma 2 Urologic Neoplasms 1 Thyroid Neoplasms 1 Soft Tissue Neoplasms 1 Sarcoma 1 Recurrence 1 Pinealoma 1 Pharyngeal Neoplasms 1 Ovarian Neoplasms 1 Neurofibromatosis 2 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Neoplasms, Mesothelial 1 Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Melanoma 1 Lymphangioleiomyomatosis 1 Lung Neoplasms 1 Familial ependymoma 1 Fallopian Tube Neoplasms 1 Erdheim-Chester Disease 1

Interventions

Cyclophosphamide 87 Etoposide 49 Carboplatin 42 Vincristine 40 Isotretinoin 40 Temozolomide 39 Topotecan 38 Melphalan 38 Irinotecan 38 Filgrastim 38 Doxorubicin 36 3-Iodobenzylguanidine 32 Cisplatin 28 Granulocyte Colony-Stimulating Factor 27 sargramostim 26 Peripheral Blood Stem Cell Transplantation 26 dinutuximab 25 Radiotherapy 24 Granulocyte-Macrophage Colony-Stimulating Factor 24 Busulfan 20 Magnetic Resonance Spectroscopy 17 fludarabine 16 aldesleukin 16 Interleukin-2 15 naxitamab 14 humanized 3F8 anti-GD2 monoclonal antibody 14 Thiotepa 13 fludarabine phosphate 12 etoposide phosphate 12 Biopsy 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02914405 2025-10-22

MiniVan

University Hospital Southampton NHS Foundation Trust

Phase 1 Active not recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡